检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients With High-Risk Follicular Lymphoma, Regardless of POD24 Status

Reid W. Merryman,David Belada,Anna Sureda,Sirpa Leppä,Joost S.P. Vermaat,Harald Holte,Martin Hutchings,Pieternella Lugtenburg,Sven de Vos,Pau Abrisqueta,Marcel Nijland,Jacob Haaber Christensen,Björn E. Wahlin,Kim M. Linton,Liwei Wang,Aqeel Abbas,Ali Rana,Syed Quadri,Lorenzo Falchi

Clinical Lymphoma, Myeloma & Leukemia（2023）

引用 0|浏览9
暂无评分
关键词
IBCL,bispecific,follicular lymphoma,hematologic malignancy,non-Hodgkin lymphoma,phase I/II
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要